Advertisement
week in cancer news
  • April 30: The Week in Cancer News

    President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.

    by Bradley Jones

  • April 23: The Week in Cancer News

    Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment, and the FDA approves an immunotherapy drug for endometrial cancer

    by Marci A. Landsmann

  • April 16: The Week in Cancer News

    Studies presented at the AACR Annual Meeting 2021 shed light on treatment of a variety of cancers, and articles discuss the risks of COVID-19 for people who have been vaccinated but are immunocompromised.

    by Kate Yandell

  • April 9: The Week in Cancer News

    A nationwide campaign encourages Americans to get their cancer screenings, and a study reports improved outcomes for patients taking oral cancer drugs when they have professional oversight.

    by Kevin McLaughlin

  • April 2: The Week in Cancer News

    A study indicates that people are delaying medical care until they are eligible for Medicare, leading to missed cancers, and the Food and Drug Administration approves the first CAR-T cell therapy for multiple myeloma.

    by Kate Yandell

  • March 26: The Week in Cancer News

    Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.

    by Bradley Jones

  • March 19: The Week in Cancer News

    A study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and experts ponder COVID-19 vaccines' role is quelling the evolution of concerning viral variants in people with weakened immune systems.

    by Marci A. Landsmann

  • March 12: The Week in Cancer News

    Lung cancer screening recommendations expand to include more smokers, and a U.K. study finds cancer patients may be less protected from COVID-19 than people without cancer after the first dose of the Pfizer-BioNTech vaccine.

    by Kevin McLaughlin

  • March 5: The Week in Cancer News

    A patient advocate and researcher argue that the U.S. has set insufficiently ambitious cervical cancer screening goals, and Merck withdraws the small cell lung cancer indication for its immunotherapy drug Keytruda.

    by Kate Yandell

  • February 26: The Week in Cancer News

    Nonprofits provide support to young cancer patients in need of fertility preservation, and a childhood cancer survivor joins the first all-civilian mission to space.

    by Bradley Jones